Dongbang FTL wins for guggulsterol process patent

Dongbang FTL said it has recently obtained a process patent for guggulsterol, which has been implicated for the treatment of disorders such as gastrointestinal disturbances, pancreatitis, gastric and pancreatic carcinomas, obesity, and cognition dysfunction.

The company noted that the patent relates to a selective method for synthesizing an economically-feasible guggulsterol having stereoiso...